Team:Cornell/Abstract

From 2011.igem.org

(Difference between revisions)
(Created page with "{{:Team:Cornell/Templates/test}} {{:Team:Cornell/Templates/hideHeader}} <h1>Project description</h1> <p> Our current proposed project for the summer is the fabrication of a micro...")
 
(2 intermediate revisions not shown)
Line 1: Line 1:
-
{{:Team:Cornell/Templates/test}}
 
{{:Team:Cornell/Templates/hideHeader}}
{{:Team:Cornell/Templates/hideHeader}}
-
<h1>Project description</h1>
+
{{:Team:Cornell/Templates/test}}
-
<p>
+
-
Our current proposed project for the summer is the fabrication of a microfluidic device for the cell-free production of bio-pharmaceuticals by binding the necessary enzymes of the pathway to the surface of the channel. The enzymes would be harvested from cellular lysate created by engineering light-induced cell death in bacterial populations which produce the needed enzymes. The hope of the team is to automate and simplify the device construction to allow for a scalable mircofluidic factory.
+
-
</p>
+
 +
 +
==''' Project description '''==
 +
Our current proposed project for the summer is the fabrication of a microfluidic device for the cell-free production of bio-pharmaceuticals by binding the necessary enzymes of the pathway to the surface of the channel. The enzymes would be harvested from cellular lysate created by engineering light-induced cell death in bacterial populations which produce the needed enzymes. The hope of the team is to automate and simplify the device construction to allow for a scalable mircofluidic factory.
{{:Team:Cornell/Templates/Menu}}
{{:Team:Cornell/Templates/Menu}}

Latest revision as of 19:47, 20 July 2011


Project description

Our current proposed project for the summer is the fabrication of a microfluidic device for the cell-free production of bio-pharmaceuticals by binding the necessary enzymes of the pathway to the surface of the channel. The enzymes would be harvested from cellular lysate created by engineering light-induced cell death in bacterial populations which produce the needed enzymes. The hope of the team is to automate and simplify the device construction to allow for a scalable mircofluidic factory.